Replacement of human plasma using sterile solution of human plasma proteins excluding blood coagulation factors
AssigneeBoitest Pharma GmbH
InventorRonald Kotitschke
Life of this patent
Estimating the term…
Abstract
To maintain an almost unchanged plasma-protein profile in a patient subsequent to plasma exchange, the plasma-exchange medium contains the most essential human serum proteins, except for the coagulation factors, at a concentration of 75 g/l.
Claims1
In the replacement of a patient's plasma with a substitute medium, the improvement which comprises employing as such substitute medium a sterile plasma-exchange medium containing the most essential human serum proteins, wherein said medium does not contain the blood coagulation factors at a concentration of about 75 g/l, and wherein said most essential human serum proteins comprise:
- ______________________________________ 10 to 80% normal blood content of antithrombin III, and 35 to 50 g/l of albumin, 6 to 12 g/l of IgG, 1.0 to 2.5 g/l of IgA, 0.5 to 2.5 g/l of IgM, 0.1 to 0.3 g/l of .alpha..sub.1 -antitrypsin, 0.1 to 0.3 g/l of .alpha..sub.2 -macroglobulin, and 0.05 to 0.15 g/l of complement C3. ______________________________________
Dependencies are inferred from the claim text.